Explore the industry's evolving mission to advance cancer research and care in this new episode of the GOLD podcast with hosts Isabel and Jade, featuring an insightful conversation with Dr Sunil Verma, Global Head of Oncology, Medical, AstraZeneca.    In this episode, Isabel uncovers Sunil's passion for working in oncology, his analysis of where cancer care has been and where it is going, why personalised medicine is the ultimate goal for oncology and an insight into the challenge that can keep him up at night.   If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

• Mapping a path to personalised medicine
• Christi Shaw on her drive to develop innovative cancer treatments
• Mental health matters in pharma’s approach to care
• Last week’s episode: Powering the new commercial model

Tune in to the next episode of the GOLD podcast to hear the team's latest conversation with a leading figure in the pharmaceutical industry. What is being discussed this week? The industry's evolving commercial model.    In this week’s episode, Isabel chats with Chetak Buaria, Vice President of Global Commercial Operations, Oncology, Merck Group, about how a new model driven by technology and data is in sight. The two explore what this new model might look like, whether pharma is ready for it and how to move forward without alienating internal or external stakeholders.   The opinions and views expressed here are his personal and do not necessarily reflect the opinions or views of Merck Healthcare KGaA, Germany or any subsidiary thereof.   If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

• Tipping the scales of KOL success
• Conquering generational differences in HCP marketing
• Is the pharma rep at death’s door?
• Last week’s episode: Getting to grips with customer experience

Join Isabel and Jade in kicking off Season 5 of the GOLD podcast with this brand-new episode, which sees the pair return to the airwaves to share more brilliant insights from experts in the pharmaceutical industry.   In this first episode, Isabel discusses customer experience with Philippe Kirby, Global Head of Channel Engagement and Execution, MSD. In the conversation, Philippe reveals what pharma is getting right and wrong, how to get valuable and actionable feedback from customers, how to balance customer experience and compliance and much more.

The GOLD team are delighted to announce that Season 5 of The GOLD Podcast is just around the corner. To mark the run up to the next series, Isabel and Jade take a moment in this episode to reminisce about some of the hot topics our brilliant guests shared with us in Season 4.   

Join our hosts as they journey through their ‘GOLD medal moments’ from last season, covering topics such as the rise of AI, the importance of empathy in leadership, the fight for representation in organisations and more. 

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

Behind the hype of ChatGPT: https://www.emg-gold.com/post/behind-the-hype-of-chatgpt 

Taking women to the top of pharma: https://www.emg-gold.com/post/taking-women-to-the-top-of-pharma 

Raising women’s health up the agenda: https://www.emg-gold.com/post/raising-women-s-health-up-the-agenda 

Medical affairs, AI and insight generation: https://www.emg-gold.com/post/medical-affairs-ai-and-insight-generation 

To mark the final episode of Season 4, Isabel and Jade reminisce about their favourite moments from the series and give an exclusive teaser for the next issue of GOLD – out on 13 April.   Expect discussion on topics such as the current state of life sciences innovation in the UK, the latest advances and potential of personalised medicine, a deep dive into our Catalyst interview with Christi Shaw, former CEO, Kite Pharma, and lots of bonus insights from the writers themselves.    Be sure to subscribe here to receive the full issue straight to your inbox on publication day.   If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

• Pharma in the UK
• Mapping a path to personalised medicine

In the penultimate episode of Season 4, the GOLD team are joined by Dr Zsuzsanna Devecseri, Vice President and Head of Global Oncology Medical, Sanofi Genzyme, to discuss her career journey and experience within the pharmaceutical industry. Isabel and Zsuzsanna explore a wide range of topics during their conversation, including diversity and inclusion, the importance of climbing the ranks of leadership at the right pace, ensuring personalised medicines can reach patients in need and much more. 

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

• Elevating pharma’s parental leave policies: https://www.emg-gold.com/post/elevating-pharma-s-parental-leave-policies 
• Setting the stage for a more equitable future: https://www.emg-gold.com/post/setting-the-stage-for-a-more-equitable-future 
• Driving access to all medicines: https://www.emg-gold.com/post/driving-access-to-all-medicines 
• Diversity: from ideas to action: https://www.emg-gold.com/post/diversity-from-ideas-to-action 

This week on the GOLD Podcast, Isabel and Jade present a conversation with Gaurav Sanganee, Managing Director and Principal Consultant, Closing Delta, about how pharmaceutical teams can make the most of a tight budget and leverage digital transformation for the benefit of customers and patients.

During their discussion, Jade and Gaurav delve into his transition from retail to pharma, explore how companies can make quick wins by leveraging modular content and omnichannel and how AI is facilitating the digital transformation of marketing strategies.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:  

• Upgrading the personal touch in CX https://www.emg-gold.com/post/upgrading-the-personal-touch-in-cx 
• AI, ChatGPT and modernising medical affairs https://www.emg-gold.com/post/ai-chatgpt-and-modernising-medical-affairs 
• Super reps, ChatGPT and pharma’s future on social media https://www.emg-gold.com/post/podcast-super-reps-chatgpt-and-pharma-s-future-on-social-media 

This week on the GOLD podcast, Isabel is joined by Matt Lewis, Co-Founder of Inizio Medical Analytics and Innovation, to discuss the future of AI in the pharmaceutical industry and the potential uses of ChatGPT in medical affairs. In this episode, Matt explores the need to modernise medical affairs, top ways pharma teams could save time and resources with ChatGPT, the likelihood of AI one day becoming as commonplace as electricity and much more. 

 

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

• Is medical affairs the Ferrari of the pharma industry?: https://www.emg-gold.com/post/podcast-is-medical-affairs-the-ferrari-of-the-pharma-industry 
• Medical affairs, AI and insight generation: https://www.emg-gold.com/post/medical-affairs-ai-and-insight-generation 
• Super reps, ChatGPT and pharma’s future on social media: https://www.emg-gold.com/post/podcast-super-reps-chatgpt-and-pharma-s-future-on-social-media 
• Revealing the true value of medical affairs: https://www.emg-gold.com/post/revealing-the-true-value-of-medical-affairs 

This week on the GOLD podcast, the team is joined by Claudia Martínez, Research Programme Manager, Generics and Diabetes Care, Access to Medicine Foundation, to discuss all things access within the pharmaceutical industry. In this episode, Claudia and Jade explore a range of topics, including the story behind her passion for access to medicine, the industry's progress in making medicines more widely available in low- and middle-income countries and the Foundation's latest focus on driving access to generic drugs. 

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

Claudia’s first GOLD Podcast: https://www.emg-gold.com/post/podcast-talking-to-claudia-martinez 

Pharma in Kenya: https://www.emg-gold.com/post/pharma-in-kenya

Pharma in India: https://www.emg-gold.com/post/pharma-in-india 

This week, the GOLD team is delighted to bring you a special International Women's Day (IWD) podcast featuring Pallavi Bansal, Associate Vice President of Oncology, Genitourinary Cancers and Haematology, Merck, and Emma Chaffin, Vice President, Country Head and Site Lead, Galapagos. The two women reflect on this year's IWD theme, #EmbracingEquity, why female representation in pharma is so important and how leaders can foster a sense of belonging within their organisations. Isabel and Jade also discuss the latest GOLD content on female representation and equality in pharma. 

Additional resources: 

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

• Infographic: Attracting more diverse talent into STEM https://www.emg-gold.com/_files/ugd/b8a9db_153874fc1b484455a9d2840f3118317c.pdf 
• Elevating pharma’s parental leave policies: https://www.emg-gold.com/post/elevating-pharma-s-parental-leave-policies 
• Reverse mentoring: a how-to guide: https://www.emg-gold.com/post/reverse-mentoring-a-how-to-guide 
• Setting the stage for a more equitable future: https://www.emg-gold.com/post/setting-the-stage-for-a-more-equitable-future 
• HBA Gender Parity Collaborative https://genderparity.hbanet.org/